secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nkarta, Inc. (NKTX)
CIK:        0001787400
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0000950170-24-002733
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nkarta posts updated corporate presentation; no specific material updates in filing excerpt
--------------------------------------------------------------------------------

- Company made available an updated corporate presentation dated January 2024.
- Presentation focuses on NK cell engineering for cancer and autoimmune diseases.
- Filed exhibit contains only a title slide; no financial data or milestones provided.
- Presentation is furnished under Regulation FD and not filed with the SEC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787400/000095017024002733/0000950170-24-002733-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787400/000095017024002733/nktx-20240108.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-002733

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer